Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Establishment of novel long-term cultures from EpCAM positive and negative circulating tumour cells from patients with metastatic gastroesophageal cancer.

Brungs D, Minaei E, Piper AK, Perry J, Splitt A, Carolan M, Ryan S, Wu XJ, Corde S, Tehei M, Aghmesheh M, Vine KL, Becker TM, Ranson M.

Sci Rep. 2020 Jan 17;10(1):539. doi: 10.1038/s41598-019-57164-6.

2.

Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.

Nimir M, Ma Y, Jeffreys SA, Opperman T, Young F, Khan T, Ding P, Chua W, Balakrishnar B, Cooper A, De Souza P, Becker TM.

Cells. 2019 Jul 8;8(7). pii: E688. doi: 10.3390/cells8070688.

3.

Expression of cancer stem cell markers is prognostic in metastatic gastroesophageal adenocarcinoma.

Brungs D, Lochhead A, Iyer A, Illemann M, Colligan P, Hirst NG, Splitt A, Liauw W, Vine KL, Pathmanandavel S, Carolan M, Becker TM, Aghmesheh M, Ranson M.

Pathology. 2019 Aug;51(5):474-480. doi: 10.1016/j.pathol.2019.03.009. Epub 2019 Jun 20.

PMID:
31230819
4.

Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status.

Po JW, Ma Y, Balakrishna B, Brungs D, Azimi F, de Souza P, Becker TM.

PLoS One. 2019 Feb 8;14(2):e0211866. doi: 10.1371/journal.pone.0211866. eCollection 2019.

5.

Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin.

Po JW, Roohullah A, Lynch D, DeFazio A, Harrison M, Harnett PR, Kennedy C, de Souza P, Becker TM.

J Circ Biomark. 2018 Jun 24;7:1849454418782617. doi: 10.1177/1849454418782617. eCollection 2018 Jan-Dec.

6.

Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer.

Brungs D, Lynch D, Luk AW, Minaei E, Ranson M, Aghmesheh M, Vine KL, Carolan M, Jaber M, de Souza P, Becker TM.

World J Gastroenterol. 2018 Feb 21;24(7):810-818. doi: 10.3748/wjg.v24.i7.810.

7.

Clinical outcomes in patients with advanced epidermal growth factor receptor-mutated non-small-cell lung cancer in South Western Sydney Local Health District.

Ding PN, Roberts TL, Chua W, Becker TM, Descallar J, Yip PY, Bray V.

Intern Med J. 2017 Dec;47(12):1405-1411. doi: 10.1111/imj.13555.

PMID:
28742280
8.

CTC-mRNA (AR-V7) Analysis from Blood Samples-Impact of Blood Collection Tube and Storage Time.

Luk AWS, Ma Y, Ding PN, Young FP, Chua W, Balakrishnar B, Dransfield DT, Souza P, Becker TM.

Int J Mol Sci. 2017 May 12;18(5). pii: E1047. doi: 10.3390/ijms18051047.

9.

The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.

Brungs D, Chen J, Aghmesheh M, Vine KL, Becker TM, Carolan MG, Ranson M.

Oncotarget. 2017 Apr 4;8(14):23099-23109. doi: 10.18632/oncotarget.15485. Review.

10.

Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood Biopsies.

Ma Y, Luk A, Young FP, Lynch D, Chua W, Balakrishnar B, de Souza P, Becker TM.

Int J Mol Sci. 2016 Aug 4;17(8). pii: E1264. doi: 10.3390/ijms17081264.

11.

Gastric cancer stem cells: evidence, potential markers, and clinical implications.

Brungs D, Aghmesheh M, Vine KL, Becker TM, Carolan MG, Ranson M.

J Gastroenterol. 2016 Apr;51(4):313-26. doi: 10.1007/s00535-015-1125-5. Epub 2015 Oct 1. Review.

PMID:
26428661
12.

BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact.

Rizos H, Menzies AM, Pupo GM, Carlino MS, Fung C, Hyman J, Haydu LE, Mijatov B, Becker TM, Boyd SC, Howle J, Saw R, Thompson JF, Kefford RF, Scolyer RA, Long GV.

Clin Cancer Res. 2014 Apr 1;20(7):1965-77. doi: 10.1158/1078-0432.CCR-13-3122. Epub 2014 Jan 24.

13.

New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use.

Becker TM, Caixeiro NJ, Lim SH, Tognela A, Kienzle N, Scott KF, Spring KJ, de Souza P.

Int J Cancer. 2014 Jun 1;134(11):2523-33. doi: 10.1002/ijc.28516. Epub 2013 Oct 29. Review.

14.

Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma.

Carlino MS, Gowrishankar K, Saunders CA, Pupo GM, Snoyman S, Zhang XD, Saw R, Becker TM, Kefford RF, Long GV, Rizos H.

Mol Cancer Ther. 2013 Jul;12(7):1332-42. doi: 10.1158/1535-7163.MCT-13-0011. Epub 2013 May 3.

15.

Secondary c-Kit mutations confer acquired resistance to RTK inhibitors in c-Kit mutant melanoma cells.

Todd JR, Becker TM, Kefford RF, Rizos H.

Pigment Cell Melanoma Res. 2013 Jul;26(4):518-26. doi: 10.1111/pcmr.12107. Epub 2013 May 13.

PMID:
23582185
16.

Vemurafenib induces senescence features in melanoma cells.

Haferkamp S, Borst A, Adam C, Becker TM, Motschenbacher S, Windhövel S, Hufnagel AL, Houben R, Meierjohann S.

J Invest Dermatol. 2013 Jun;133(6):1601-9. doi: 10.1038/jid.2013.6. Epub 2013 Feb 14.

17.

Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.

Boyd SC, Mijatov B, Pupo GM, Tran SL, Gowrishankar K, Shaw HM, Goding CR, Scolyer RA, Mann GJ, Kefford RF, Rizos H, Becker TM.

J Invest Dermatol. 2013 May;133(5):1269-77. doi: 10.1038/jid.2012.421. Epub 2012 Nov 29.

18.

Absence of distinguishing senescence traits in human melanocytic nevi.

Tran SL, Haferkamp S, Scurr LL, Gowrishankar K, Becker TM, Desilva C, Thompson JF, Scolyer RA, Kefford RF, Rizos H.

J Invest Dermatol. 2012 Sep;132(9):2226-34. doi: 10.1038/jid.2012.126. Epub 2012 Apr 19.

19.

Acquired resistance to BRAF inhibition can confer cross-resistance to combined BRAF/MEK inhibition.

Gowrishankar K, Snoyman S, Pupo GM, Becker TM, Kefford RF, Rizos H.

J Invest Dermatol. 2012 Jul;132(7):1850-9. doi: 10.1038/jid.2012.63. Epub 2012 Mar 22. Erratum in: J Invest Dermatol. 2013 Oct;133(10):2493.

20.

Selective loss of wild-type p16(INK4a) expression in human nevi.

Scurr LL, McKenzie HA, Becker TM, Irvine M, Lai K, Mann GJ, Scolyer RA, Kefford RF, Rizos H.

J Invest Dermatol. 2011 Nov;131(11):2329-32. doi: 10.1038/jid.2011.197. Epub 2011 Jul 7. No abstract available.

Supplemental Content

Loading ...
Support Center